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OBJECTIVE: The objective of this selective EBM review is to determine whether or not obese 
patients have a better quality of life after undergoing gastric bypass rather than sleeve 
gastrectomy.  
 
STUDY DESIGN: A review of 3 randomized controlled trials (RCT) that were published after 
2014.  
 
DATA SOURCES: The 3 peer-reviewed randomized controlled trials were found through 
PubMed. All studies were published in English.   
 
OUTCOMES MEASURED: The outcome measured in these RCTs was overall change in 
quality of life after sleeve gastrectomy and gastric bypass. This was done by patients responding 
to questionnaires. Two articles Ignat et al. and Peterli et al. used the Gastrointestinal Quality of 
Life Index and Murphy et al. used the physical functioning on the SF-36 subscale questionnaire.  
 
RESULTS: The RCT performed by Murphy et al. showed significant positive change from 
baseline in quality of life one year after surgery for both groups (P<0.001), but no significance 
between the 2 different surgical interventions (P=0.41). Similarly, Ignat et al. also showed 
improvement of quality life from baseline one year after surgery (P<0.001) and no significance 
between the 2 groups (P=0.323). Lastly, Peterli et al. further supported the enhancement in 
quality of life one year after surgery in both the gastric bypass and sleeve gastrectomy (P=0.003, 
P=0.001) with no significant difference found between the 2 interventions (P=0.366).  
 
CONCLUSION: The review of these 3 RCTs provides information on the ability of bariatric 
surgery to improve QoL. Statical significance was noted for change from baseline in all 3 studies 
with no significance between the 2 intervention groups of sleeve gastrectomy and gastric bypass. 
Both types of surgery are effective ways to improve quality of life although sleeve gastrectomy 
is not superior, but comparable, to gastric bypass.  
 
KEY WORDS: obesity, bariatric surgery, quality of life 
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INTRODUCTION  
 
 Obesity is a chronic condition where an individual has excess amounts of adipose tissue 
and a state of low-grade inflammation. It can contribute to conditions like cardiovascular disease, 
diabetes, and hypertension. Additionally, it contributes to metabolic dysfunction of glucose and 
lipids as well as immune dysfunction.1 Research states the main reason for obesity is excessive 
energy intake compared to expenditure, an imbalance in the caloric intake and output. There is 
also genetic predisposition which can play a role. In other situations, endocrine disorders, as well 
as medication, and psychiatric conditions can cause obesity. Hormones like leptin, ghrelin, and 
insulin can contribute if they are imbalanced.2 Obesity can be a very serious risk factor to many 
different conditions, predisposing individuals to future health issues. It has been shown to 
decrease quality of life and increase risk for psychological disorders as well.3  
When it comes to treating the chronic condition, there are different methods that are used 
depending on the patient’s BMI. The defining factors for BMI are as follows: overweight BMI: 
>25-29.9 kg/m2, obese stage 1 BMI: 30-34.9 kg/m2, obese stage 2 BMI: 35-39.9 kg/m2, obese 
stage 3 BMI: 40 kg/m2 or above. Evaluating the patient’s BMI and previous attempts on losing 
the excess adipose tissue help to determine the treatment approach for the patient.  
 The first step for treatment in obese individuals is to change dietary intake, by altering 
their caloric intake quantity as well as quality. Patients should consume less calories than they 
are expending as well as calories that are high in nutrients to keep the body healthy. Along with 
change in diet, patients need to increase their physical activity to burn more calories. This is done 
through lifestyle modifications as well as beginning exercise routines or simply moving more 
throughout the day.2 The next step in treatment for obese individuals is pharmaceuticals. Some 
medications that are used for eliminating excess adipose tissue are Contrave, Lorcaserin, 
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Qsymia, and Xenical.2 These can be used in combination with dietary restrictions and lifestyle 
modifications for people who have not succeeded with them alone or have a higher BMI. The 
final step to treatment for patients who have severe obesity is bariatric surgery. The different 
surgical approaches are sleeve gastrectomy, gastric bypass, and adjustable gastric banding.2  
Although all of the different treatments are options for obese individuals, the focus of this 
paper is to compare 2 different surgical approaches, sleeve gastrectomy and gastric bypass. 
Specifically, it will evaluate how each one of these surgical approaches affect the quality of life 
in individuals one year post-operation. Quality of life (QoL) is extremely important for all 
individuals and as stated is many times decreased in obese individuals.3 The surgical treatment 
plans for assisting in weight loss have shown to improve quality of life in individuals and this 
paper will evaluate if sleeve gastrectomy has greater improvements than gastric bypass.  
The focus on treatment for obesity is pertinent to the current practice of healthcare 
providers due to the high prevalence in society. Currently in the country, 39.8% of the population 
over the age of 20 years old is obese.4 This number is also continuing to increase and many 
patients that providers encounter are overweight or obese. This is relevant to practice due to the 
high volume of patients that suffer from the disease as well as its consequences. Some of the 
conditions that are associated with obesity are cancer, type 2 diabetes, heart disease, as well as 
strokes.5 Because of such high prevalence as well as other medical conditions that can be caused 
by increase in adipose tissue, it is essential that providers can give patients an effective treatment 
plan to help control their body weight.  
As well as being so common, the cost of the disease itself is very expensive. In 2008, it 
was reported that the national average cost for patients that were obese and overweight was 
113.9 billion dollars, obesity accounted for 98.1 billion dollars. That accounts for 5-10% of all 
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medical costs in the United States healthcare system.6 So, not only are there high numbers of 
people that are living with the chronic disease, but the consequence of healthcare costs is also 
affecting the healthcare system. Additionally, there were 11 million annual visits made in the 
U.S. for obesity in 2012 for patients who were 20 years and older.7 These values show how much 
the disease affects not only the patients, but also providers. Due to the large volume of 
Americans suffering, it is pertinent for physician assistants and other healthcare providers to be 
comfortable with treatment plans for their patients as well as have information to help decide the 
best approach for them. This paper can assist in providing information to patients who are 
seeking a surgical intervention as their treatment plan.  
OBJECTIVE  
The objective of this selective EBM review is to determine whether or not obese patients 
have a better quality of life after undergoing gastric bypass rather than a sleeve gastrectomy.  
METHODS  
Three RCTs were found via PubMed focusing on bariatric surgery in obese adults. In 
search for relevant articles, population criteria was restricted to adult, obese patients. The 
intervention that was used for the search criteria was sleeve gastrectomy and the comparison 
group was gastric bypass surgery. Criteria for outcomes measures was restricted to overall 
change in quality of life one year after the operation. The types of studies considered were 
randomized controlled trials.  
Keywords included were “obesity,” “sleeve gastrectomy,” “gastric bypass,” “quality of 
life.” All articles were published in English. Articles were found through the PubMed database 
and were selected based on the type of trial that was performed, relevance of the article to the 
topic and the use of POEM outcomes that compared well to the other articles selected. Inclusion 
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criteria for selecting articles consist of RCT, English, published after 2014, involved gastric 
bypass and sleeve gastrectomy. The exclusion criteria for the article selection was articles 
published before 2014, not assessing quality of life, and were not RCT. The summary of 
statistics were reported by the mean change from baseline and p-value.  
Table 1. Demographics & characteristics of included studies  
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OUTCOMES MEASURED  
 The outcomes measured for all three articles is quality of life one year post-operation. 
This was measured by Gastrointestinal Quality of Life Index in two articles and physical 
functioning on the SF-36 subscale questionnaire in the other article. The Gastrointestinal Quality 
of Life Index is a 0-4 scale survey, the higher score being a higher QoL, given to the patient to 
evaluate their overall emotional function in 5 questions, social function (4 questions), 19 
questions on gastrointestinal symptoms, treatment assessment (1 question), and physical function 
(7 questions).8 
RESULTS 
 Murphy et al.9 compared sleeve gastrectomy from gastric bypass in a randomized control 
study to assess the differences in 2 types of bariatric surgery. Patients recruited for the study 
were obese adult patients who have type 2 diabetes. More information about patient inclusion 
and exclusion criteria can be found in Table 1. 58 patients were randomly assigned to receive the 
laparoscopic sleeve gastrectomy and 56 patients were randomly assigned to the laparoscopic 
gastric bypass group.9 Patients were evaluated prior and followed up for analysis at one year 
post-operation. The study included 114 patients and a total of 5 patients were lost at follow-up. 
Quality of life was measured from the five SF-36 subscales evaluation; one of the subscales 
assesses physical functioning.9 This is the value that was used to evaluate the change in QoL for 
patients who undergo bariatric surgery. A change from baseline was used to evaluate the 
improvement or lack thereof in the 2 interventions. A student’s t-test or Mann-Whitney U test 
were used to assess the between-group comparisons; a two-sided p-value <0.05 was considered 
significant.9 The values were presented as means with standard deviations assessing the change 
from their baseline rating on the QoL scale. The researchers found that for the group 
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comparisons one year post-operation there was no statistically significant difference (P=0.41) 
between the sleeve gastrectomy and gastric bypass groups. That said, the change from baseline in 
both groups was significant (P<0.001).9 Based on the evaluation of change from baseline, there 
is a large treatment effect in both sleeve gastrectomy and gastric bypass (Table 2).  
Table 2. Murphy et al. mean change from baseline assessing QoL ±  SD9  
 Change from 
baseline 
p-value p-value between 
groups  
Gastric Bypass 24.00 ±  31.45 P <0.001*  
P=0.41* Sleeve 
Gastrectomy 
19.51 ±  23.20 P <0.001* 
*= Statically significant <0.05  
 
Ignat et al.8 is a randomized control trial that is evaluating differences between gastric 
bypass surgery and sleeve gastrectomy in University Hospital of Strasbourg, France. 105 patients 
were chosen based on the inclusion and exclusion criteria as stated in Table 1. Patients were 
randomized by closed envelopes into either the Roux-en-Y gastric bypass intervention group or 
the sleeve gastrectomy intervention group. Patients underwent the surgical procedure and were 
assessed one year later for change in quality of life since the surgery.8 As stated, 105 patients 
began the study, but 8 patients were lost at follow-up. Additional interventions were needed in 
13% of the gastric bypass group and 4% in the sleeve gastrectomy group.8 In the gastric bypass 
group interventions included a follow-up laparotomy, one had a postoperative bleed, an internal 
hernia repair, and a patient got peritonitis. Additionally, 3 patients from the sleeve gastrectomy 
group converted to the gastric bypass group. Quality of life was assessed in each intervention 
group and was presented as mean change from baseline and standard deviation. Statistical 
analysis of EWL was used with time as the level 1 predictor and treatment group was the level 2 
predictor.8 Then, the student’s t-test with Bonferroni correction for multiple comparisons was 
used for the between group comparison, along with the Wilcoxon-Mann-Whitney test. For the 
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categorical variable p-values, the Fisher’s exact test was used and p<0.05 was considered 
significantly significant. With that said, the change from baseline for both the sleeve gastrectomy 
and gastric bypass interventions were both significant (p<0.001) as seen in Table 3.8 
Additionally, with the values listed in Table 3 representing mean change from baseline, there 
was a large treatment effect. That said, when comparing change between the 2 interventions, 
there was no statistical significance (p=0.323).8 
Table 3. Ignat et al. mean change from baseline assessing QoL8  






Gastric Bypass 96.4 ± 16.0 113.8 ± 16.4 p  <0.001* 17.4  
p=0.323* Sleeve 
Gastrectomy 
90.7 ± 16.3 113.9 ± 17.1 p <0.001* 23.2 
*= Statically significant <0.05  
 
Peterli et al.10 present a randomized control trial comparing change in QoL among 
patients who receive bariatric surgery, either sleeve gastrectomy or gastric bypass. In this study, 
125 patients were divided into 2 different intervention groups to evaluate the effects of the 
different surgical methods. At the one-year follow-up 8 patients were lost and therefore excluded 
from the data. One patient crossed over to the sleeve gastrectomy group and 7 were not operated 
on before the deadline.10 Patients were selected based on the inclusion and exclusion criteria that 
are described in Table 1. After surgery was performed, 9 patients from the sleeve gastrectomy 
group needed additional surgeries from complications like gallstones, requiring cholecystectomy. 
Some patients also converted over to the gastric bypass group because they did not lose 
sufficient weight.10 From the gastric bypass group 16 patients needed additional surgery for 
conditions like hernias, small bowel obstructions, and infections. One patient needed a resection 
of Meckel diverticulum. Data from this study was evaluated with IBM SPSS for Windows and 
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student t-test, Fisher exact two-sided tests, and chi-square test.10 The statistical significance was 
set at p<0.05. For the purpose of this paper, the focus is on evaluation of QoL one-year after 
surgery, and Peterli et al. used the Gastrointestinal Quality of Life Index to do so. From the data 
collected through the questionnaires it was found that both of the intervention groups 
significantly improved QoL (p=0.001, p=0.003).10 This is seen through mean values and 
standard deviations represented as change from baseline (Table 4). Besides the change after one-
year, between group change was also compared and this was not statistically significant 
(p=0.366).10  
Table 4. Peterli et al. mean change from baseline assessing QoL10  





Gastric Bypass 99.3 ± 20.6 128.5 ± 9.3 p  <0.003* 29.2  
p=0.366* Sleeve 
Gastrectomy 
100.0 ± 20.6 126.3 ± 13.4 p <0.001* 26.3 
*= Statically significant <0.05  
 
DISCUSSION 
 Obesity is a debilitating disease that increases morbidity and mortality in many 
individuals in the United States. This chronic condition has many negative effects on a patient’s 
health and causes deterioration of multiple body systems like the heart, kidney, nervous, and 
musculoskeletal system. When considering bariatric surgery, certain relative contraindications 
need to be considered. There are no absolute contraindications to surgery, but weighing benefit 
versus risk for certain patients is essential. Careful decision making should be present in patients 
with active cancer treatment, drug/alcohol dependency, severe heart failure, and end-stage lung 
disease.11 Bariatric Surgery is indicated in patients with BMI >40 kg/m2 or >35 kg/m2 with co-
morbidities. Obesity-related comorbidities include hypertension, obstructive sleep apnea, urinary 
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incontinence, GERD, asthma, arthritis, diabetes, and hyperlipidemia.11 All of these indications 
and contraindications need to be considered in patients who are interested in discussing bariatric 
surgery as an option for weight loss. Some complications may also occur as previously noted by 
research. Surgical interventions have led to anastomotic leaks, surgical site infection, internal 
hernias and ulcers, and injuries to internal organs. Some more rarer complications that have been 
noted are myocardial infarctions, hemorrhages, and pulmonary embolism.11 As well as 
indications and contraindications, it is also important to be aware of complications that can occur 
from the procedure. That said, there are many positive outcomes that come from the different 
interventions and surgery can be beneficial to the patient and their ability to live a healthy life.  
This systematic review gathered research to see benefits that result from a patient 
receiving a bariatric surgery intervention, specifically change in overall quality of life. All 3 of 
the studies focused on the mean change from baseline one-year post-operation for individuals 
who volunteered to have gastric bypass or sleeve gastrectomy. All articles had consistent data 
about changes in quality of life for both interventions. The 3 articles assessed by Murphy et al.,9 
Peterli et al.,10 and Ignat et al.8 had data to support that there was improvement in quality of life 
for patients in the sleeve gastrectomy and the gastric bypass groups. The purpose of this paper 
was to assess if sleeve gastrectomy produced a higher improvement of quality of life than the 
gastric bypass. From the information found, sleeve gastrectomy does not produce a QoL greater 
than gastric bypass. Data showed no statistically significant difference in change between 
groups, so they both may overall have similar effects on QoL.8-10  
 Along with the conclusions drawn from each study, there were also limitations noted by 
the researchers. Murphy et al.9 notes that the lack of a control group could be a limitation of the 
study, but from previous data, surgery has superior outcomes then medical interventions. Other 
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limitations are the small sample size and the fact that the procedure only takes place in one 
center, making the conclusions more difficult to generalize. Additionally, no worst-case analysis 
was done, so some of the results could be skewed. Peterli et al.10 states that limitations to the 
research done by them includes the fact that there were a low number of diabetic patients in each 
group, so they are unsure how that affects the outcome. Also, they note that there were numerous 
reoperation rates, a total of 15, which could also be a limitation to the data they collected. 
Blinding was not used in this study and outcomes were still measured subjectively, therefore 
results could be bias because participants have more information that can sway their decision 
making. Lastly, Ignat et al.8 reports that limitations to their study could include the high number 
of patients that were lost to follow-up because the hospital was further away for many people. As 
well as, there were many more women than men in the study, so sex could be another limitation. 
Intention to treat analysis was not completed as well as worst case analysis which could both 
have altered the outcomes and made the results less reliable. When conducting the research, the 
inclusion criteria focused on obese individuals, but not any other co-morbidities. This could be a 
limitation due to the fact that studies used different inclusion criteria for patients and other 
coexisting illnesses could play a role in the patient outcomes. This may change the outcomes 
slightly for how individuals view their QoL. Additionally, the focus of QoL is a subjective 
measure, therefore many outside factors besides the surgery could affect how people respond to 
the questionnaire. This could be a limitation because there are other life factors that play a role in 
deciding how a patient may feel on that day they are assessing their QoL.   
CONCLUSION 
 From the information collected from the 3 different randomized control trials in this 
systematic review, it can be concluded that bariatric surgery is beneficial for improvements in 
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QoL. Specifically, sleeve gastrectomy does not have a greater improvement than gastric bypass 
intervention. All 3 studies concluded that there is no statistically significant difference in the 
improvement of overall QoL between the study groups. This is supported by data from baseline 
QoL and change one-year post-operation in trials conducted by Murphy et al.,9 Peterli et al.,10 
and Ignat et al.8 Therefore, each intervention can be successfully used for assistance in weight 
loss in adult obese patients looking to enhance their QoL.  
 Future studies could include an additional intervention group that consists of an 
adjustable band intervention. It would be interesting to see how other types of surgery compare 
to the 2 more widely used methods. This information could be useful for individuals who are 
eligible for bariatric surgery and are looking for information to assist in their decision making for 
choosing a procedure. Additionally, considering a control group for comparison may be 
beneficial as stated by Murphy et al.,9 as long as it remains ethical. Other comparison groups to 
compare to may also include a group that focuses on lifestyle changes including increasing 
exercise and dietary alterations as well as pharmaceutical groups. As stated when evaluating 
limitations, future studies can include worst case analyses and intention to treat analyses to 
ensure validity of the data that is presented. Additionally, adding blinding to each protocol can 
help to reduce bias. The more studies that are carried out could help to generalize the information 
to all patients that are eligible for bariatric surgery, this information can be beneficial to patients 
who may not be aware of all their options and the positive outcomes that come along with 
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